The Telomere System in Cord Blood and in the Placenta in High Risk Pregnancies
NCT01384136 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2011-06-28
Summary
The telomere system stabilizes the chromosomes. Telomeres are shortened during senescence, in cases of genetic instability and secondary to stress.
The investigators aim is to study the telomere system in cord blood and in the placenta immediately after the delivery in pregnancies defined as high risk pregnancies following sterss events such as placental insufficiency, preeclampsia, diabetes.
The investigators intend to compare the telomere system in maternal blood to cord blood and to placental biopsies and to study the influence of different stressogenes on this system.
Conditions
- Telomere Length
- Mechanisms of Telomter Homeostasis
- High Risk Pregnancies
Sponsors & Collaborators
-
Meir Medical Center
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-06-30
- Primary Completion
- 2015-06-30
- Completion
- 2015-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Detection of Thyrotrophin Receptor in Human Myometrium
NCT01348191 ·Status: COMPLETED
-
Cyclin-dependent Kinase Inhibitor 2A (Placental Senescence Marker) on Labor-related Signals
NCT05864066 ·Status: UNKNOWN
-
High Risk Multiple Gestation Study
NCT02278874 ·Status: COMPLETED
-
Technology Development for Noninvasive Prenatal Genetic Diagnosis Using Whole Fetal Cells From Maternal Peripheral Blood
NCT04285814 ·Status: COMPLETED
-
"Circulating Fetal DNA, Pregnancy And Immune Diseases"
NCT04155086 ·Status: UNKNOWN ·Phase: NA
-
Breakpoint Analysis of de Novo Apparently Balanced Chromosomal Translocations
NCT01826708 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Non-Invasive Determination of Fetal Chromosome Abnormalities
NCT00891852 ·Status: UNKNOWN
-
Study of Placental Function in Healthy and Pathological Pregnancies
NCT02321007 ·Status: RECRUITING
-
Identification of Early Predictors of Fetomaternal Hemorrhage
NCT01232387 ·Status: COMPLETED
-
Identifying HDL Composition and Function in Preeclamptic and Normal Pregnancies
NCT02554604 ·Status: COMPLETED
-
Detection of Risk Factors for Fetal Anomalies in a Rural Hospital Population
NCT01662596 ·Status: UNKNOWN
-
Free DNA and Nucleosome Concentrations in Pathological Pregnancies
NCT01736826 ·Status: COMPLETED
-
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
NCT01429389 ·Status: RECRUITING
-
Clinical Evaluation of the SEQureDx T21 Test In High Risk Pregnancies
NCT01555346 ·Status: COMPLETED
-
Development of a Diagnostic Device for Identifying Between Amniotic Fluid to Urine
NCT01022814 ·Status: UNKNOWN
-
Cell-free Fetal DNA Circulating in the Maternal Plasma as a Marker for Morbidly Adherent Placenta
NCT02784886 ·Status: UNKNOWN
-
Trisomy of Chromosome 21 Diagnosis by High Output Sequencing
NCT01118507 ·Status: COMPLETED
-
Progesterone for First Trimester Vaginal Bleeding
NCT01501890 ·Status: WITHDRAWN ·Phase: NA
-
Ultra-early Identification of Fetal Chromosomal Characteristics From Extravillous-trophoblast Cells
NCT06523543 ·Status: RECRUITING
-
Prenatal Analysis of Cell-free Circulating Fetal DNA
NCT06864806 ·Status: RECRUITING ·Phase: NA
-
PROMComplete for Determination of Rupture of Fetal Membranes
NCT02369601 ·Status: UNKNOWN
-
Development of a Prenatal Test for Fetal Aneuploidy Detection
NCT01451671 ·Status: COMPLETED
-
Transplacental Gradients and Transport in Intrauterine Growth Restricted (IUGR) Pregnancies Compared to Normal Pregnancies.
NCT02397291 ·Status: TERMINATED ·Phase: NA
-
Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood
NCT00064597 ·Status: UNKNOWN
-
Clinical Evaluation of the SEQureDx Trisomy Test in Low Risk Pregnancies
NCT01597063 ·Status: COMPLETED